iShares Nasdaq Biotechnology (IBB) Poised to Open Up Over 2%
Tweet
Share
E-mailiShares Nasdaq Biotechnology (NASDAQ: IBB) is poised to open higher by over 2%. Top holdings in the ETF are Biogen Idec (NASDAQ: BIIB), Celgene (NASDAQ: CELG), Gilead Sciences (NASDAQ: GILD), Amgen (NASDAQ: AMGN), and Regeneron (NASDAQ: REGN).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Therapeutics files for proposed IPO
- Anthropic: launching research preview of model hardware standard
- Rupert Murdoch considering re-merger of Fox Corp and News Corp - Reuters
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
